Naistentautien ja synnytysten yksikkö
Department of Obstetrics and Gynaecology

Julkaisut 2006
Publications 2006

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Castrén M et al. Kantasolut hermoston kehityshäiriön kuvaajina särö-X-oireyhtymässä.
2 Grenman S et al. A randomised phase III study comparing hihg-dose chemotherapy to conventionally dosed chemotherapy for stage III ovariab cancer: the Finnish Ovarian Cancer (FINOVA) study.
3 Heikkilä K et al. Assessment of attitudes towards assisted reproduction: A survey among medical students and parous women.
4 Heinonen S. Critical evaluation of evidence: a lesson to learn from a recent meta-analysis.
5 Heinonen S. Gene therapy and ovarian cancer-more questions than answers.
6 Heiskanen N et al. Mikrobilääkkeiden käyttö raskauden ja imetyksen aikana-suositukset puoltavat tuttua ja turvallista.
7 Heiskanen N et al. Fetal macrosomia-a continuing obstetric challenge.
8 Hoffrén P et al. Miten käyttökelpoisia ja turvallisia ovat äitiyshuollon synnytyskertomusjärjestelmät?
9 Hovi M et al. Obstetric outcome in post-term pregnancies: time for reappraisal in clinical mangement.
10 Hyvärinen A et al. Sensorineural hearing loss after epidural block for labor analgesia: a case report.
11 Jääskeläinen E et al. MTHFR C677T polymorphism is not associated with placental abruption or preeclampsia in finnish women.
12 Komi J et al. Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women.
13 Kouri P et al. Online discussions mirroring family life during pregnancy.
14 Kouri P et al. Pregnant families' discussions on the net - from virtual connections toward real-life community.
15 Kumpulainen S et al. Surgical treatment of ovarian cancer in different hospital categories - a prospective nation-wide study in Finland.
16 Lehtonen J et al. Nascent body ego: metapsychological and neurophysiological aspects.
17 Mäenpää JU et al. Sequential gemcitabine-carboplatin followed by paclitaxel-carboplatin in the first-line treatment of advanced ovarian cancer: A phase II study.
18 Ollikainen M et al. Jononpurkuprojekti Kuopion yliopistollisessa sairaalassa 2002-2003. Mitä tapahtui suonikohjupotilaille ja miten projekti koettiin?
19 Paavonen J, Heinonen S. EVO-tutkimusrahoituksen uusjako uhkaa lopettaa kliinisen lääketieteellisen tutkimuksen.
20 Pentti K et al. Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study.
21 Raatikainen K, Heinonen S. Lihavuus on vaaraksi raskaudelle.
22 Raatikainen K et al. Transition from overweight to obesity worsens pregnancy outcome in a BMI-depentent manner.
23 Raatikainen K et al. Does unemployment in family affect pregnacy outcome in conditions of high quality maternity care?
24 Raatikainen K et al. Induced abortion: not an independent risk factor for pregnancy outcome, but a challelge for health counseling.
25 Raatikainen K et al. Good outcome of teenages pregnancies in high-quality maternity care.
26 Randell KM et al. Fracture risk and bone density of peri- and early postmenopausal women with uterine leiomyomas.
27 Rikkonen T et al. Distance of walking in childhood and femoral bne density in perimenopausal women.
28 Rissanen A et al. Pregnancy-associated plasma protein A, free human chorionic gonadotrophin and nuchal translucency as predictors of miscarriage.
29 Saarela T. Susceptibility Genes of Diabetes and Endothelial Dysfunction in Preeclampsia.
30 Saarela T et al. Plasma cell membrane glycoprotein-1 K121Qmpolymorphism in preeclampsia.
31 Saarela T et al. Adiponectin gene haplotype is associated with preeclampsia.
32 Saarela T et al. Polymorphisms of interleukin-6, hepatic lipase and calpain-10 genes, and preeclampsia.
33 Saarelainen H et al. Pregnancy-related hyperlipidemia and endothelial function in healthy women.
34 Sallinen H et al. A highly reproducible xenograft model for human ovarian carcinoma and application of MRI and ultrasound in longitudinal follow-up.
35 Sillanpää SM et al. Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
36 Sirola J et al. Maintenance of muscle strength may counteract weight-loss-related postmenopausal bone loss - a population based approach.
37 Sirola J et al. Association of grip strength change with menopausal bone loss and related fractures: A population-based follow-up study.
38 Sirola J et al. Mikkelin Osteoporoosi -indeksi (MOI) ennustaa osteoporoottisia murtumia.
39 Tuhkanen H. DNA Copy Number Changes in the Stromal and Epithelial Cells of Ovarian and Breast Tumours.
40 Tuhkanen H et al. Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas.
41 Tuppurainen M et al. Periytyvätkö osteoporoosi ja luunmurtumat?
42 Viinikainen K et al. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children.
43 Viinikainen K et al. Community-based, prostective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.
44 Voutilainen KA et al. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.

Naistentautien ja synnytysten yksikkö Department of Obstetrics and Gynaecology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008